BioPharma Credit PLC
BPCP.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | £122,178 | £108,450 | £182,311 | £84,959 |
| Dep. & Amort. | £0 | £0 | £0 | £0 |
| Deferred Tax | £0 | £0 | £0 | £0 |
| Stock-Based Comp. | £0 | £0 | £0 | £0 |
| Change in WC | -£10,358 | -£9,220 | £7,884 | -£12,294 |
| Other Non-Cash | £92 | £23,952 | -£5,918 | £23,771 |
| Operating Cash Flow | £111,912 | £123,182 | £184,277 | £96,436 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | £0 | £0 | £0 | £0 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | -£36,656 | -£100,000 | -£187,141 |
| Inv. Sales/Matur. | £39,072 | £35,000 | £148,194 | £92,320 |
| Other Inv. Act. | £0 | £0 | £0 | £0 |
| Investing Cash Flow | £39,072 | -£1,656 | £48,194 | -£94,821 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £0 | £0 | £0 | £0 |
| Stock Repurch. | -£105,753 | -£17,220 | -£50,087 | £0 |
| Dividends Paid | -£174,662 | -£89,773 | -£156,537 | -£100,157 |
| Other Fin. Act. | £0 | £0 | £0 | £0 |
| Financing Cash Flow | -£280,415 | -£106,993 | -£206,624 | -£100,157 |
| Forex Effect | -£2 | -£7 | -£29 | -£18 |
| Net Chg. in Cash | -£129,433 | £14,526 | £25,818 | -£98,560 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £135,053 | £120,527 | £94,709 | £193,269 |
| End Cash | £5,620 | £135,053 | £120,527 | £94,709 |
| Free Cash Flow | £111,912 | £123,182 | £184,277 | £96,436 |